QR Code

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort

BACKGROUND Hepatitis C virus (HCV) infections in Switzerland are mainly related to intravenous drug use. Since 2017, all patients with chronic hepatitis C can be treated with direct-acting antivirals (DAAs) irrespective of fibrosis stage. In March 2019, the Federal Office of Public Healt...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Andrea Bregenzer, Philip Bruggmann, Erika Castro, Alberto Moriggia, Madeleine Rothen, Maria Christine Thurnheer, Pietro Vernazza, Claude Scheidegger
Hōputu: Artigo
Reo:Inglês
I whakaputaina: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2021-03-01
Rangatū:Swiss Medical Weekly
Ngā marau:
direct-acting antivirals
interferon
opioid agonist therapy (OAT)
cohort
Switzerland
HCV-cascade
Urunga tuihono:https://www.smw.ch/index.php/smw/article/view/2970
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite